IBUPROFEN, ACETAMINOPHEN

IBUPROFEN, ACETAMINOPHEN was reported 2787 times

IBUPROFEN, ACETAMINOPHEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1591 0.0543
1 DRUG EFFECT FASTER THAN EXPECTED 8 0.0240
2 COCKROACH ALLERGY 1 0.0208
3 DRUG EFFECT LESS THAN EXPECTED 147 0.0099
4 PRODUCT USE IN UNAPPROVED INDICATION 1717 0.0069
5 CHRONIC RHINOSINUSITIS WITH NASAL POLYPS 1 0.0068
6 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0054
7 THERAPEUTIC PRODUCT EFFECT DELAYED 20 0.0044
8 VESTIBULAR MIGRAINE 1 0.0041
9 PRODUCT USED FOR UNKNOWN INDICATION 5 0.0040
10 DEPOSIT EYE 1 0.0037
11 DUPLICATE THERAPY ERROR 1 0.0031
12 PROSTATIC PAIN 1 0.0025
13 SPINAL DECOMPRESSION 1 0.0024
14 MYCOTIC ALLERGY 2 0.0023
15 MEDICATION OVERUSE HEADACHE 2 0.0023
16 THERAPEUTIC PRODUCT EFFECT VARIABLE 9 0.0023
17 ALLERGY TO PLANTS 1 0.0022
18 DRAINAGE 1 0.0020
19 THERAPEUTIC RESPONSE UNEXPECTED 90 0.0020
20 INTRAOCULAR PRESSURE DECREASED 1 0.0019
21 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 135 0.0019
22 EPHELIDES 1 0.0019
23 NAIL INJURY 1 0.0018
24 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 87 0.0016
25 PERNICIOUS ANAEMIA 1 0.0016
26 ALCOHOL INTOLERANCE 1 0.0014
27 HEART SOUNDS ABNORMAL 1 0.0013
28 RENAL HAEMANGIOMA 1 0.0013
29 AXIAL SPONDYLOARTHRITIS 1 0.0011
30 BONE CONTUSION 1 0.0011
31 CANCER SURGERY 1 0.0010
32 EPIGASTRIC DISCOMFORT 4 0.0010
33 INCORRECT DOSAGE ADMINISTERED 5 0.0010
34 HAEMANGIOMA OF LIVER 1 0.0010
35 PRODUCT SELECTION ERROR 1 0.0009
36 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
37 INFECTED CYST 1 0.0008
38 TUMOUR PAIN 1 0.0008
39 LIP EXFOLIATION 1 0.0008
40 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
41 BLOOD ELECTROLYTES DECREASED 1 0.0007
42 RUBBER SENSITIVITY 1 0.0007
43 CONTRAINDICATED PRODUCT ADMINISTERED 19 0.0006
44 PRODUCT COMPLAINT 15 0.0006
45 MILIARIA 1 0.0006
46 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
47 HANGOVER 2 0.0006
48 FOOD INTERACTION 1 0.0006
49 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
50 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
51 EYELID PAIN 1 0.0005
52 POLYCYTHAEMIA 1 0.0005
53 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
54 SPINAL COLUMN INJURY 1 0.0004
55 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
56 DISLOCATION OF VERTEBRA 1 0.0004
57 PRODUCT PACKAGING CONFUSION 1 0.0004
58 EYELID IRRITATION 1 0.0004
59 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
60 ABDOMINAL RIGIDITY 1 0.0004
61 GASTRIC PERFORATION 1 0.0004
62 RENAL CANCER STAGE IV 1 0.0004
63 HEART RATE ABNORMAL 2 0.0004
64 DRUG TOLERANCE DECREASED 1 0.0004
65 HEART VALVE INCOMPETENCE 1 0.0003
66 CREPITATIONS 1 0.0003
67 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 6 0.0003
68 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
69 FOREIGN BODY IN THROAT 1 0.0003
70 PHOTOPSIA 2 0.0003
71 FACET JOINT SYNDROME 1 0.0003
72 PHARYNGEAL SWELLING 3 0.0003
73 LYME DISEASE 1 0.0003
74 POSTOPERATIVE WOUND INFECTION 2 0.0003
75 WRONG PRODUCT ADMINISTERED 2 0.0003
76 ABDOMINAL DISCOMFORT 48 0.0003
77 SCRATCH 3 0.0003
78 SKIN WEEPING 1 0.0003
79 PARANASAL SINUS DISCOMFORT 1 0.0003
80 DRUG INEFFECTIVE 344 0.0003
81 PROSTATOMEGALY 1 0.0003
82 PRODUCT USE COMPLAINT 4 0.0003
83 INTENTIONAL PRODUCT MISUSE 22 0.0003
84 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
85 TONGUE DISCOMFORT 1 0.0002
86 TEARFULNESS 1 0.0002
87 RENAL CELL CARCINOMA 1 0.0002
88 VITREOUS FLOATERS 2 0.0002
89 LIGAMENT SPRAIN 2 0.0002
90 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
91 INCORRECT DOSE ADMINISTERED 46 0.0002
92 HYPOAESTHESIA ORAL 3 0.0002
93 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 35 0.0002
94 RENAL PAIN 2 0.0002
95 PRODUCT SIZE ISSUE 1 0.0002
96 PHARYNGITIS STREPTOCOCCAL 2 0.0002
97 INFUSION SITE EXTRAVASATION 1 0.0002
98 SWELLING OF EYELID 1 0.0002
99 FEELING JITTERY 3 0.0002
100 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
101 BREAST CANCER STAGE III 1 0.0002
102 APPETITE DISORDER 1 0.0002
103 SINUS CONGESTION 2 0.0001
104 ULCER HAEMORRHAGE 1 0.0001
105 PRODUCT TASTE ABNORMAL 2 0.0001
106 PRODUCT LABEL ISSUE 1 0.0001
107 IMPAIRED GASTRIC EMPTYING 2 0.0001
108 DEFAECATION URGENCY 1 0.0001
109 ABDOMINAL PAIN UPPER 29 0.0001
110 FEAR OF INJECTION 1 0.0001
111 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
112 PARAESTHESIA ORAL 2 0.0001
113 FAECES SOFT 1 0.0001
114 INTENTIONAL UNDERDOSE 1 0.0001
115 SKIN HAEMORRHAGE 2 0.0001
116 FEELING DRUNK 1 0.0001
117 DUODENAL ULCER PERFORATION 1 0.0001
118 BOWEL MOVEMENT IRREGULARITY 1 0.0001
119 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
120 ULCER 2 0.0001
121 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
122 SOMNOLENCE 25 0.0001
123 SKIN HYPERPIGMENTATION 1 0.0001
124 DISCOMFORT 7 0.0001
125 HEAD DISCOMFORT 2 0.0001
126 EXPOSURE DURING PREGNANCY 7 0.0001
127 PRODUCT USE ISSUE 21 0.0001
128 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
129 RESTLESS LEGS SYNDROME 2 0.0001
130 HIDRADENITIS 1 0.0001
131 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
132 FLANK PAIN 1 0.0001
133 ARTERIOSCLEROSIS 1 0.0001
134 INFLAMMATORY BOWEL DISEASE 1 0.0001
135 PRODUCT ADMINISTRATION ERROR 2 0.0001
136 VAGINAL DISCHARGE 1 0.0001
137 SLUGGISHNESS 1 0.0001
138 FEELING HOT 6 0.0001
139 HELICOBACTER INFECTION 1 0.0001
140 PRODUCT ODOUR ABNORMAL 1 0.0001
141 FOLLICULITIS 1 0.0001
142 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
143 BIPOLAR DISORDER 1 0.0001
144 SKIN LACERATION 1 0.0001
145 PULMONARY THROMBOSIS 1 0.0001
146 INJECTION SITE NODULE 1 0.0001
147 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
148 LIVER DISORDER 4 0.0001
149 SNEEZING 2 0.0001
150 OCULAR DISCOMFORT 1 0.0001
151 CHROMATURIA 2 0.0001
152 DERMATITIS CONTACT 1 0.0001
153 NEOPLASM 1 0.0001
154 GASTRIC HAEMORRHAGE 1 0.0001
155 ACCIDENT 1 0.0001
156 BURSITIS 1 0.0001
157 FIBROMYALGIA 2 0.0001
158 LIVER INJURY 2 0.0001
159 MUSCLE SPASTICITY 1 0.0001
160 TOOTH EXTRACTION 1 0.0001
161 INJECTION SITE IRRITATION 1 0.0001
162 GASTROINTESTINAL DISORDER 7 0.0001
163 ROTATOR CUFF SYNDROME 1 0.0001
164 ILLNESS 8 0.0001
165 HIATUS HERNIA 1 0.0001
166 HAND DEFORMITY 1 0.0001
167 BEDRIDDEN 1 0.0001
168 GASTRITIS 2 0.0001
169 HYPERSENSITIVITY 14 0.0001
170 JOINT RANGE OF MOTION DECREASED 1 0.0001
171 EXTRA DOSE ADMINISTERED 3 0.0001
172 FREQUENT BOWEL MOVEMENTS 2 0.0001
173 MIGRAINE 7 0.0001
174 GINGIVAL BLEEDING 1 0.0001
175 CORONARY ARTERY OCCLUSION 1 0.0001
176 MEDICATION ERROR 4 0.0001
177 HUNGER 1 0.0001
178 COORDINATION ABNORMAL 1 0.0001
179 DYSGEUSIA 5 0.0001
180 COLON CANCER 1 0.0001
181 ILL-DEFINED DISORDER 4 0.0001
182 TINNITUS 3 0.0001
183 DEVICE RELATED INFECTION 1 0.0001
184 MUSCULOSKELETAL CHEST PAIN 1 0.0001
185 RENAL DISORDER 3 0.0001
186 THERAPY PARTIAL RESPONDER 1 0.0001
187 BASAL CELL CARCINOMA 1 0.0001
188 SWOLLEN TONGUE 2 0.0001
189 BRAIN FOG 1 0.0001
190 SCIATICA 1 0.0001
191 EXPIRED PRODUCT ADMINISTERED 2 0.0001
192 VIRAL INFECTION 2 0.0001
193 LIP SWELLING 2 0.0001
194 FUNGAL INFECTION 2 0.0001
195 HEPATIC ENZYME INCREASED 4 0.0001
196 INFLAMMATION 3 0.0001
197 ECZEMA 3 0.0001
198 PRODUCT STORAGE ERROR 5 0.0001
199 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
200 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
201 GASTROENTERITIS VIRAL 1 0.0001
202 TOOTHACHE 1 0.0001
203 PANIC ATTACK 2 0.0001
204 HEPATIC STEATOSIS 1 0.0001
205 SLEEP APNOEA SYNDROME 1 0.0001
206 LOWER LIMB FRACTURE 1 0.0001
207 EAR PAIN 1 0.0001
208 CHOKING 1 0.0001
209 SINUS DISORDER 1 0.0001
210 COMPLICATION OF DEVICE INSERTION 1 0.0001
211 PRODUCT PHYSICAL ISSUE 1 0.0000
212 DRY MOUTH 4 0.0000
213 INJECTION SITE WARMTH 1 0.0000
214 TOOTH LOSS 1 0.0000
215 KNEE ARTHROPLASTY 1 0.0000
216 SKIN EXFOLIATION 4 0.0000
217 JOINT INJURY 1 0.0000
218 IMPAIRED WORK ABILITY 1 0.0000
219 IRRITABLE BOWEL SYNDROME 1 0.0000
220 POOR QUALITY SLEEP 1 0.0000
221 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
222 FAECES DISCOLOURED 1 0.0000
223 PRODUCT DISPENSING ERROR 1 0.0000
224 PRODUCT PRESCRIBING ISSUE 1 0.0000
225 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
226 GLOSSODYNIA 1 0.0000
227 CHEST PAIN 8 0.0000
228 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
229 OCULAR HYPERAEMIA 2 0.0000
230 DYSPHAGIA 4 0.0000
231 DISEASE RECURRENCE 2 0.0000
232 RASH ERYTHEMATOUS 2 0.0000
233 MENTAL IMPAIRMENT 1 0.0000
234 NEURALGIA 1 0.0000
235 INJECTION SITE URTICARIA 1 0.0000
236 DYSPEPSIA 4 0.0000
237 PNEUMONIA ASPIRATION 1 0.0000
238 HEADACHE 25 0.0000
239 CELLULITIS 2 0.0000
240 CARDIOVASCULAR DISORDER 1 0.0000
241 PRURITUS 15 0.0000
242 ANAPHYLACTIC SHOCK 1 0.0000
243 HAEMATOMA 1 0.0000
244 RESPIRATORY TRACT INFECTION 1 0.0000
245 HAEMORRHAGE 4 0.0000
246 DEAFNESS 1 0.0000
247 SPEECH DISORDER 2 0.0000
248 EAR INFECTION 1 0.0000
249 THROMBOSIS 3 0.0000
250 SKIN LESION 1 0.0000
251 ABNORMAL DREAMS 1 0.0000
252 ARTHROPATHY 2 0.0000
253 BLISTER 2 0.0000
254 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
255 HYPERSOMNIA 1 0.0000
256 DYSSTASIA 1 0.0000
257 RENAL INJURY 1 0.0000
258 APHASIA 1 0.0000
259 LACRIMATION INCREASED 1 0.0000
260 THERAPEUTIC RESPONSE DECREASED 2 0.0000
261 STOMATITIS 2 0.0000
262 CONDITION AGGRAVATED 10 0.0000
263 INJECTION SITE RASH 1 0.0000
264 PERIPHERAL SWELLING 5 0.0000
265 OROPHARYNGEAL PAIN 3 0.0000
266 SWELLING 3 0.0000
267 PARAESTHESIA 5 0.0000
268 MOOD SWINGS 1 0.0000
269 INTENTIONAL OVERDOSE 2 0.0000
270 SWELLING FACE 2 0.0000
271 IMPAIRED HEALING 1 0.0000
272 EYE DISORDER 1 0.0000
273 INFUSION RELATED REACTION 2 0.0000
274 TREMOR 5 0.0000
275 SKIN DISORDER 1 0.0000
276 GAIT INABILITY 1 0.0000
277 ANGER 1 0.0000
278 FEELING ABNORMAL 7 0.0000
279 DELIRIUM 1 0.0000
280 RASH MACULAR 1 0.0000
281 HYPERTENSION 6 0.0000
282 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
283 DIZZINESS 14 0.0000
284 ACCIDENTAL OVERDOSE 1 0.0000
285 EYE SWELLING 1 0.0000
286 NAUSEA 21 0.0000
287 MUSCULAR WEAKNESS 3 0.0000
288 COLITIS 1 0.0000
289 CHRONIC KIDNEY DISEASE 2 0.0000
290 BLOOD PRESSURE INCREASED 4 0.0000
291 FATIGUE 20 0.0000
292 COUGH 7 0.0000
293 ABORTION SPONTANEOUS 1 0.0000
294 JOINT SWELLING 3 0.0000
295 DYSKINESIA 1 0.0000
296 OSTEOPOROSIS 1 0.0000
297 VISUAL IMPAIRMENT 3 0.0000
298 WITHDRAWAL SYNDROME 1 0.0000
299 HYPERHIDROSIS 3 0.0000
300 MENTAL DISORDER 1 0.0000
301 OFF LABEL USE 20 0.0000
302 COLITIS ULCERATIVE 1 0.0000
303 THROAT IRRITATION 1 0.0000
304 ADVERSE DRUG REACTION 2 0.0000
305 THERAPY NON-RESPONDER 1 0.0000
306 SUICIDAL IDEATION 2 0.0000
307 SKIN IRRITATION 1 0.0000
308 NEPHROLITHIASIS 1 0.0000
309 ADVERSE EVENT 2 0.0000
310 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
311 BACK PAIN 5 0.0000
312 BLOOD CHOLESTEROL INCREASED 1 0.0000
313 PAIN 13 0.0000
314 ANXIETY 6 0.0000
315 PRODUCTIVE COUGH 1 0.0000
316 MULTIPLE SCLEROSIS 1 0.0000
317 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
318 CONTUSION 2 0.0000
319 DRUG INTOLERANCE 2 0.0000
320 MALAISE 9 0.0000
321 PRODUCT DOSE OMISSION ISSUE 6 0.0000
322 HYPOAESTHESIA 3 0.0000
323 DRY EYE 1 0.0000
324 FLUSHING 2 0.0000
325 CHEST DISCOMFORT 2 0.0000
326 SINUSITIS 2 0.0000
327 DYSPNOEA 11 0.0000
328 ARTHRALGIA 8 0.0000
329 VOMITING 9 0.0000
330 INSOMNIA 5 0.0000
331 DISTURBANCE IN ATTENTION 1 0.0000
332 RASH PRURITIC 1 0.0000
333 OEDEMA 1 0.0000
334 RASH 8 0.0000
335 HAEMATOCHEZIA 1 0.0000
336 ANAPHYLACTIC REACTION 1 0.0000
337 URTICARIA 3 0.0000
338 NECK PAIN 1 0.0000
339 EYE PAIN 1 0.0000
340 MYALGIA 3 0.0000
341 FLATULENCE 1 0.0000
342 URINARY TRACT INFECTION 3 0.0000
343 HERPES ZOSTER 1 0.0000
344 EYE IRRITATION 1 0.0000
345 DECREASED APPETITE 4 0.0000
346 COVID-19 3 0.0000
347 DYSPHONIA 1 0.0000
348 PALPITATIONS 2 0.0000
349 BONE PAIN 1 0.0000
350 PAIN IN EXTREMITY 5 0.0000
351 CATARACT 1 0.0000
352 IRRITABILITY 1 0.0000
353 VERTIGO 1 0.0000
354 MUSCLE SPASMS 3 0.0000
355 NASOPHARYNGITIS 3 0.0000
356 INJECTION SITE ERYTHEMA 2 0.0000
357 ASTHENIA 6 0.0000
358 LOSS OF CONSCIOUSNESS 2 0.0000
359 AMNESIA 1 0.0000
360 PSORIASIS 2 0.0000
361 BLOOD PRESSURE DECREASED 1 0.0000
362 INJECTION SITE PRURITUS 1 0.0000
363 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
364 INJURY 1 0.0000
365 SKIN BURNING SENSATION 1 0.0000
366 CONSTIPATION 3 0.0000
367 BRONCHITIS 1 0.0000
368 EPISTAXIS 1 0.0000
369 HALLUCINATION 1 0.0000
370 DEPRESSION 3 0.0000
371 INJECTION SITE SWELLING 1 0.0000
372 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
373 DIARRHOEA 8 0.0000
374 CONFUSIONAL STATE 2 0.0000
375 PNEUMONIA 4 0.0000
376 INFLUENZA LIKE ILLNESS 1 0.0000
377 MUSCULOSKELETAL STIFFNESS 1 0.0000
378 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
379 PULMONARY EMBOLISM 1 0.0000
380 NEUROPATHY PERIPHERAL 1 0.0000
381 GAIT DISTURBANCE 2 0.0000
382 HEART RATE INCREASED 1 0.0000
383 SYNCOPE 1 0.0000
384 INJECTION SITE PAIN 3 0.0000
385 ERYTHEMA 2 0.0000
386 ABDOMINAL DISTENSION 1 0.0000
387 OVERDOSE 2 0.0000
388 FALL 3 0.0000
389 ASTHMA 1 0.0000
390 RHEUMATOID ARTHRITIS 1 0.0000
391 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
392 CHILLS 1 0.0000
393 OEDEMA PERIPHERAL 1 0.0000
394 DRY SKIN 1 0.0000
395 VISION BLURRED 1 0.0000
396 INFECTION 1 0.0000
397 DRUG INTERACTION 1 0.0000
398 DRUG DEPENDENCE 1 0.0000
399 TOXICITY TO VARIOUS AGENTS 1 0.0000
400 CEREBROVASCULAR ACCIDENT 1 0.0000
401 MYOCARDIAL INFARCTION 1 0.0000
402 NO ADVERSE EVENT 1 0.0000
403 BLOOD GLUCOSE INCREASED 1 0.0000
404 ANAEMIA 1 0.0000
405 ALOPECIA 1 0.0000
406 WEIGHT INCREASED 1 0.0000
407 WEIGHT DECREASED 1 0.0000
408 PYREXIA 1 0.0000
409 DEATH 1 0.0000